Jacobo Cabrera-Ramirez, MD
Pain Medicine · Gilbert, AZNPI 1942792981
Payments from drug & device makers
What this record shows
14 manufacturers reported payments, led by Saluda Medical Americas, Inc. at 26.0% of the total.
Across 114 payments — averaging $106.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Saluda Medical Americas, Inc.$3K
- Abbott$2K
- Boston Scientific$1K
- Nalu Medical, Inc.$1K
- Medtronic$1K
- MML US, Inc.$762
- plus $2K from 8 others
What the payments were for
- Travel & lodging$6,68155%
- Food & beverage$5,40345%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Saluda Medical Americas, Inc. | 31 | $3,142 |
| Abbott | 22 | $2,435 |
| Boston Scientific | 13 | $1,486 |
| Nalu Medical, Inc. | 12 | $1,272 |
| Medtronic | 11 | $1,114 |
| MML US, Inc. | 4 | $762 |
| Biotronik NRO, Inc. | 6 | $660 |
| Nevro Corp. | 7 | $631 |
| SPR Therapeutics, Inc | 3 | $288 |
| Avanos Medical | 1 | $129 |
| Averitas Pharma Inc. | 1 | $75 |
| Globus Medical | 1 | $68 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
| Foundation Fusion Solutions, LLC | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Evoke$2,367
- PROCLAIM$1,859
- Nalu Neurostimulation System$1,119
- ReActiv8$633
- INTELLIS ADAPTIVESTIM$625
- Prospera$555
- Superion Indirect Decompression System$458
- Senza$404
- KYPHON EXPRESS II KYPHOPAK TRAY$159
- WaveWriter Alpha Prime 16$146
- GENERATOR$129
- OCTRODE$125
- SPRINT PNS System$124
- NAVLOCK$106
How this compares
$12,084 in reported general payments places this provider in the 75th percentile of 180 pain medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 63 | $1,427 |
| Pregabalin | 57 | $974 |
| Celecoxib | 22 | $512 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $275 |
| Baclofen | 19 | $221 |
| Oxycodone Hcl | 15 | $212 |
| Methocarbamol | 12 | $189 |
| Duloxetine Hcl | 18 | $172 |
| Methylprednisolone | 21 | $136 |
| Tizanidine Hcl | 12 | $132 |
| Tramadol Hcl | 18 | $94 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Gilbert
- Ryan GibbGilbert$12K
- Kurt LundbergGilbert$11K
- Eric CornidezTucson$496K
- Tory McJunkinScottsdale$204K
- Minesh ZaveriPhoenix$187K
- Chad PletnickOro Valley$137K
- Tristan PicoChandler$121K
- Selaiman NooriLake Havasu City$104K
- Christine HaddadPhoenix$98K
- Samir PatelOro Valley$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.